hypertension Flashcards
define hypertension
high blood pressure
aetiology
primary : unknown secondary accelerated/malignant white coat masked - clinic different to home/ABPM
aetiology of secondary hypertension
kidney disease - glomerulonephritis, diabetic nephropathy, renal cell carcinoma
vascular disease - renal artery stenosis, coarctation of aorta
endocrine disease - primary hyperaldosteronism, cushing’s, acromegaly
drugs - corticosteroids, venlafaxine, alcohol
connective tissue disorder
obstructive sleep apnoea
gestational hypertension
pre-eclampsia
outcome of untreated hypertension
brain : stroke (ischaemic/haemorrhagic) vascular dementia heart : CAD, PVD, cardiac arrythmias, heart failure, heart attack eye : hypertensive retinopathy kidneys : chronic kidney disease
treatment
lifestyle changes - healthy diet, exercise, reducing dietary salt intake, caffeine consumption, alcohol consumption, smoking cessation
medical - stepwise approach
stages of hypertension
stage 1 = >140/90mmHg (clinic), >135/85 (ABPM/HBPM)
stage 2 = >160/100mmHg , >150/95
stage 3 = >180/120mmHg , —
bedside investigations
urinalysis
urine albumin creatinine ratio (uACR) - albuminuria suggests end-organ damage
ECG
lab investigations
urea and electrolytes
HbA1c - indicates blood glucose conc over previous 3mnths - high suggests diabetes
lipid profile - useful for assessing CVS disease risk
what tool can be used for assessing CVS disease risk
QRISK3
target BP for patients <80years
clinic = <140/90mmHg
ABPM/HBPM = 135/85mmHg
target BP for patients aged >80 years
clinic = 150/90mmHg
ABPM/HBPM = <145/85mmHg
medical management for stage 1
discuss anti-hypertensive drug therapy w/ patients <80 years who have 1 or more of … CVS disease, kidney disease, or estimated 10yr risk of CVS disease
consider anti-hypertensive drug therapy in patients…
aged >80yrs with clinic BP >150/90mmHg
aged <60yrs with estimated 10yr risk of CVS disease
medical management for stage 2&3
offer anti-hypertensive drug therapy to all patients (NICE guidelines)
stepwise approach, min of 4wks to determine combination of drugs/drug have been successful at reducing BP or not
step 1 of stepwise approach
patients aged <55yrs not of black african/caribbean descent : offer ACE inhibitor (ramipril), if not tolerated offer angiotensin-ii receptor blocker such as losartan
patients >55yrs and of black african/caribbean descent : offer CCB such as amlodipine
step 2 of stepwise approach
patients already taking ACE inhibitor or ARB offer CCB or a thiazide-type diuretic such as indapamide
patients already taking CCB : offer ACE inhibitor or a thiazide-type diuretic such as indapamide
if ACE not tolerated offer ARB